Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions.

Cytokine receptors act through a complex signaling network, involving Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs), to regulate diverse biological processes which control growth, development, homeostasis and immune function, among others. The JAK/STAT signaling pathway is attenuated via three mechanisms controlling the initiation, magnitude, and duration of the signal: the PIAS proteins, which prevent STAT dimerization or DNA interaction, the SHP phosphatases, which dephosphorylate activating tyrosine phosphorylations, and the suppressors of cytokine signaling (SOCS), which are transcribed in response to cytokine stimulation and use several interconnected mechanisms to downregulate the signal. Specific studies targeting the SOCS genes in vivo have unveiled SOCS2 as the main regulator of somatic growth through regulation of GH/IGF-1 signaling. In addition, several studies indicate that SOCS2 also has important actions in the central nervous system, the regulation of metabolism, the immune response, the mammary gland development, cancer, and other cytokine-dependent signaling pathways. Consistent with the role of cytokines in human physiology, any SOCS2 imbalance could result in a broad range of pathologies such as cardiovascular diseases, insulin resistance, cancer, and severe infections, among others. Thus, determining the importance of SOCS2 in health and disease will no doubt aid in the development of novel therapeutic strategies. In this review, we attempt to summarize the available information, including our results, regarding the role of SOCS2 in several biological processes.

[1]  Naoto Nakamura,et al.  Association of single-nucleotide polymorphisms in the suppressor of cytokine signaling 2 (SOCS2) gene with type 2 diabetes in the Japanese. , 2006, Genomics.

[2]  K. Sjögren,et al.  Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Kelly,et al.  Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor. , 2001, Endocrinology.

[4]  A. Jegalian,et al.  Differential roles of SOCS family members in EpoR signal transduction. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[5]  D. Harrison,et al.  The JAK/STAT signaling pathway , 2004, Journal of Cell Science.

[6]  J. Kopchick,et al.  Transgenic models of growth hormone action. , 1999, Annual review of nutrition.

[7]  W. Alexander,et al.  Gigantism in mice lacking suppressor of cytokine signalling-2 , 2000, Nature.

[8]  A. Yoshimura,et al.  Negative regulation of cytokine and TLR signalings by SOCS and others. , 2005, Advances in immunology.

[9]  M. Wong,et al.  Structural characterization of the mouse high growth deletion and discovery of a novel fusion transcript between suppressor of cytokine signaling-2 (Socs-2) and viral encoded semaphorin receptor (Plexin C1). , 2002, Gene.

[10]  Sergio Wittlin,et al.  Differential hypermethylation of SOCS genes in ovarian and breast carcinomas , 2004, Oncogene.

[11]  P. Kelly,et al.  Inhibition and Restoration of Prolactin Signal Transduction by Suppressors of Cytokine Signaling* , 1999, The Journal of Biological Chemistry.

[12]  A. Turnley,et al.  Expression of “suppressor of cytokine signalling” (SOCS) genes in the developing and adult mouse nervous system , 2000, The Journal of comparative neurology.

[13]  Giampiero Girolomoni,et al.  Impaired IFN-γ-Dependent Inflammatory Responses in Human Keratinocytes Overexpressing the Suppressor of Cytokine Signaling 11 , 2002, The Journal of Immunology.

[14]  G. Norstedt,et al.  Negative regulation of growth hormone receptor signaling. , 2006, Molecular endocrinology.

[15]  Warren S Alexander,et al.  Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects. , 2005, Molecular endocrinology.

[16]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[17]  Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling. , 2000 .

[18]  T. Naka,et al.  Regulation of cytokine signaling by SOCS family molecules. , 2003, Trends in immunology.

[19]  C. Paul,et al.  Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization. , 2000, European journal of biochemistry.

[20]  B. Gao,et al.  IL‐10 attenuates IFN‐α‐activated STAT1 in the liver: involvement of SOCS2 and SOCS3 , 2000 .

[21]  R. Wilkins,et al.  STAT5b mediates the GH-induced expression of SOCS-2 and SOCS-3 mRNA in the liver , 1999, Molecular and Cellular Endocrinology.

[22]  A. Colao,et al.  Extensive personal experience: Acromegaly , 1997 .

[23]  Perry F. Bartlett,et al.  Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling , 2002, Nature Neuroscience.

[24]  Claes Ohlsson,et al.  SOCS2 negatively regulates growth hormone action in vitro and in vivo. , 2005, The Journal of clinical investigation.

[25]  D. Hilton,et al.  Growth Hormone Preferentially Induces the Rapid, Transient Expression of SOCS-3, a Novel Inhibitor of Cytokine Receptor Signaling* , 1998, The Journal of Biological Chemistry.

[26]  Maithao Le,et al.  Insulin Induction of SOCS-2 and SOCS-3 mRNA Expression in C2C12 Skeletal Muscle Cells Is Mediated by Stat5* , 2001, The Journal of Biological Chemistry.

[27]  Stefan Knapp,et al.  Crystal structure of the SOCS2–elongin C–elongin B complex defines a prototypical SOCS box ubiquitin ligase , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Marchetti,et al.  Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. , 2005, European journal of endocrinology.

[29]  D. Levy,et al.  Mechanism of STAT3 Activation by Insulin-like Growth Factor I Receptor* , 2000, The Journal of Biological Chemistry.

[30]  J. Johnston,et al.  SOCS2 Can Enhance Interleukin-2 (IL-2) and IL-3 Signaling by Accelerating SOCS3 Degradation , 2005, Molecular and Cellular Biology.

[31]  Takaho A. Endo,et al.  A new protein containing an SH2 domain that inhibits JAK kinases , 1997, Nature.

[32]  S. Asa,et al.  Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). , 2002, Molecular endocrinology.

[33]  A. Turnley,et al.  Suppressor of cytokine signalling‐2 and epidermal growth factor regulate neurite outgrowth of cortical neurons , 2004, The European journal of neuroscience.

[34]  J. G. Zhang,et al.  SOCS1 deficiency results in accelerated mammary gland development and rescues lactation in prolactin receptor-deficient mice. , 2001, Genes & development.

[35]  G. Jenster,et al.  Evolution of the androgen receptor pathway during progression of prostate cancer. , 2006, Cancer research.

[36]  J. Medrano,et al.  Diet effects on weight gain and body composition in high growth (hg/hg) mice. , 2000, Physiological genomics.

[37]  J. Melo,et al.  Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanism. , 2002, Blood.

[38]  E. Brown,et al.  Global transcription profiling of estrogen activity: estrogen receptor alpha regulates gene expression in the kidney. , 2003, Endocrinology.

[39]  P. Kelly,et al.  Dual effects of suppressor of cytokine signaling (SOCS‐2) on growth hormone signal transduction , 1999, FEBS letters.

[40]  T. Naka,et al.  Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. , 1997, Biochemical and biophysical research communications.

[41]  I. Campbell Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS , 2005, Brain Research Reviews.

[42]  Jan Tavernier,et al.  Design and application of a cytokine-receptor-based interaction trap , 2001, Nature Cell Biology.

[43]  A. Stavreus-Evers,et al.  Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. , 1999, Endocrinology.

[44]  I. Arany,et al.  The endogenous interferon system in anal squamous epithelial lesions with different grades from HIV-positive individuals , 2001, International journal of STD & AIDS.

[45]  J. Visvader,et al.  Socs2 and elf5 mediate prolactin-induced mammary gland development. , 2006, Molecular endocrinology.

[46]  T. Kishimoto,et al.  gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation. , 2000, Cytokine.

[47]  W. Alexander,et al.  Biological Evidence That SOCS-2 Can Act Either as an Enhancer or Suppressor of Growth Hormone Signaling* , 2002, The Journal of Biological Chemistry.

[48]  J. Flier,et al.  Activation of SOCS-3 Messenger Ribonucleic Acid in the Hypothalamus by Ciliary Neurotrophic Factor. , 1999, Endocrinology.

[49]  G. Norstedt,et al.  Endoplasmic reticulum stress prolongs GH-induced Janus kinase (JAK2)/signal transducer and activator of transcription (STAT5) signaling pathway. , 2001, Molecular endocrinology.

[50]  C. Geisler,et al.  Interferon-Alpha Induces Transient Suppressors of Cytokine Signalling Expression in Human T Cells , 2001, Experimental and Clinical Immunogenetics.

[51]  A. Flores-Morales,et al.  Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton. , 2004, Experimental cell research.

[52]  W. Alexander,et al.  The SOCS box: a tale of destruction and degradation. , 2002, Trends in biochemical sciences.

[53]  W. Alexander,et al.  Suppressors of cytokine signalling and regulation of growth hormone action. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[54]  M. Waters,et al.  Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness , 2004, The European journal of neuroscience.

[55]  D. Hilton,et al.  Negative regulation of cytokine signaling , 2001, Journal of leukocyte biology.

[56]  C. Mantzoros,et al.  Unlike leptin, ciliary neurotrophic factor does not reverse the starvation-induced changes of serum corticosterone and hypothalamic neuropeptide levels but induces expression of hypothalamic inhibitors of leptin signaling. , 2000, Diabetes.

[57]  D. Hilton,et al.  Tissue-specific induction of SOCS gene expression by PRL. , 2001, Endocrinology.

[58]  J. Powell,et al.  Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. , 2005, International immunology.

[59]  T. Famula,et al.  Evidence for a major gene for rapid postweaning growth in mice. , 1984, Genetical research.

[60]  C. Ling,et al.  PRL Receptor-Mediated Effects in Female Mouse Adipocytes: PRL Induces Suppressors of Cytokine Signaling Expression and Suppresses Insulin-Induced Leptin Production in Adipocytes in Vitro. , 2001, Endocrinology.

[61]  M. Chopp,et al.  Erythropoietin up-regulates SOCS2 in neuronal progenitor cells derived from SVZ of adult rat , 2004, Neuroreport.

[62]  K. Rakesh,et al.  Controlling cytokine signaling by constitutive inhibitors. , 2005, Biochemical pharmacology.

[63]  J. Johndrow,et al.  Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent , 2006, Nature Medicine.

[64]  P. Rotwein,et al.  In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. , 2004, American journal of physiology. Endocrinology and metabolism.

[65]  D. Waxman,et al.  SOCS/CIS Protein Inhibition of Growth Hormone-stimulated STAT5 Signaling by Multiple Mechanisms* , 1999, The Journal of Biological Chemistry.

[66]  E. Hooghe-Peters,et al.  Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines , 2000, Journal of Neuroimmunology.

[67]  Z. Estrov,et al.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia. , 2003, Blood.

[68]  S. Mohan,et al.  Reduced Bone Mineral Density in SOCS-2-Deficient Mice , 2005, Pediatric Research.

[69]  T. Zacharewski,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Suppressor of Cytokine Signaling 2 in Murine B Cells , 2004, Molecular Pharmacology.

[70]  Carmen Z. Michaylira,et al.  Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[71]  A. Yoshimura,et al.  Negative regulation of cytokine signaling and immune responses by SOCS proteins , 2005, Arthritis research & therapy.

[72]  S. Knuutila,et al.  Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array , 2002, Oncogene.

[73]  J. Johnston,et al.  SOCS: role in inflammation, allergy and homeostasis. , 2004, Trends in immunology.

[74]  K. Shuai,et al.  The Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 but Not SOCS2 Proteins Inhibit Interferon-mediated Antiviral and Antiproliferative Activities* , 1998, The Journal of Biological Chemistry.

[75]  D. Meyer,et al.  The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. , 1996, Molecular endocrinology.

[76]  A. Turnley Role of SOCS2 in growth hormone actions , 2005, Trends in Endocrinology & Metabolism.

[77]  I. Kawase,et al.  SOCS‐2 interferes with myotube formation and potentiates osteoblast differentiation through upregulation of JunB in C2C12 cells , 2006, Journal of cellular physiology.

[78]  S. Akira,et al.  Structure and function of a new STAT-induced STAT inhibitor , 1997, Nature.

[79]  B. R. Dey,et al.  Interaction of Human Suppressor of Cytokine Signaling (SOCS)-2 with the Insulin-like Growth Factor-I Receptor* , 1998, The Journal of Biological Chemistry.

[80]  S. Horvat,et al.  Lack of Socs2 expression causes the high-growth phenotype in mice. , 2001, Genomics.

[81]  Carmen Z. Michaylira,et al.  Suppressor of cytokine signaling-2: a growth hormone-inducible inhibitor of intestinal epithelial cell proliferation. , 2004, Gastroenterology.

[82]  J. Tavernier,et al.  A complex interaction pattern of CIS and SOCS2 with the leptin receptor , 2006, Journal of Cell Science.

[83]  Hannah J. Scott,et al.  SOCS2 Induces Neurite Outgrowth by Regulation of Epidermal Growth Factor Receptor Activation* , 2004, Journal of Biological Chemistry.